Dec 15 (Reuters) - Arch Biopartners Inc ARCH.V :
* ARCH BIOPARTNERS RECEIVES GOVERNMENT OF CANADA FUNDING TO SUPPORT PHASE II THERAPEUTIC TRIAL OF METABLOK FOR COVID-19
* ARCH BIOPARTNERS INC - CANADA AWARDED A CONTRIBUTION OF UP TO $6.7 MILLION TO SUPPORT PHASE II DEVELOPMENT OF METABLOK